BioSpace News Archive

NeuroSense Therapeutics Ltd. announced it will host an investor webinar conference on Tuesday, September 12, 2023 from 8:30 AM to 9:15 AM Eastern Time.

HighLife SAS announced the introduction of a new valve size in its clinical trials, the Large Annulus Valve, designed for patients with larger anatomies.

BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that US sales of its flagship product VINIA® in the month of August have crossed the USD 1Million per month line.

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company”), a medical device company commercializing IzoView

The National Disease Research Interchange has been awarded $3.7M by the National Institutes of Health to support continued national leadership with the recovery and distribution of human organs and tissues for medical research.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), and Janssen PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (“Janssen PMP”) are pleased to announce a significant expansion to their existing Exclusive Evaluation and Option Agreement

Japanese technology company Asahi Kasei will showcase diversified material solutions for safe and compact EV batteries, improved connectivity and lightweighting, as well as circular economy at Fakuma, the world’s leading trade event for industrial plastics processing, from October 17th to 21st, 2023 in Friedrichshafen, Germany.

Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating promising treatments to market with its transformative AnovaOS™ technology platform, and the industry’s first collaborative ‘learning system’, today announced a partnership with Dizal Pharmaceuticals (Dizal) to accelerate the development of DZD9008 for patients with EGFR Exon20ins mutant NSCLC.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced Great Place To Work® and Fortune magazine have named Myriad Genetics to the 2023 Fortune Best Workplaces in Health Care™ List.

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in complement, announced that the company approved the grant of equity awards to 5 new employees with a grant date of September 1, 2023, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan and material to the employees’ acceptance of employment with the company.